Sanofi reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sanofi using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-24 | $1.70 | $1.60 | 6.31 % |
| Q2 | 2025-07-31 | $0.90 | $0.96 | -6.15 % |
| Q1 | 2025-04-24 | $0.94 | $0.95 | -0.95 % |
| Q4 | 2025-01-30 | $0.70 | $0.74 | -5.41 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-24 | $14.54B | $14.46B | 0.54 % |
| Q2 | 2025-07-31 | $11.33B | $11.53B | -1.72 % |
| Q1 | 2025-04-24 | $10.41B | $9.77B | 6.51 % |
| Q4 | 2025-01-30 | $11.28B | $10.57B | 6.67 % |
Sanofi (SNY) is scheduled to report earnings on January 29, 2026. The last reported earnings were for reported on October 24, 2025 for Q3.
The Actual EPS was $1.70, which beat the estimate of $1.60.
The Actual Revenue was $14.5B, which beat the estimate of $14.5B.
Browse earnings estimates, EPS, and revenue on all stocks.